Collin A. Rich, PhD
Collin Rich’s entrepreneurial successes include launching and managing R&D and operational activities at OcuSciences as well as five other medical device start-ups in the ophthalmic, cardiac/vascular, ultrasound, histology, and immunology spaces over the past 22 years—including as co-founder of Accuri Cytometers, which was ultimately sold to Becton Dickinson. His formal training as an Electrical Engineer is augmented by familiarity with a wide variety of fluidic, optical, mechanical, and other technologies, as well as practical experience managing the fast-paced activity of an aggressive, innovative R&D team and close collaboration with manufacturing and operational teams. He is co-inventor on over 53 U.S. and international patents. Dr. Rich earned his PhD in Electrical Engineering from the University of Michigan.